Updated Jul 16, 2026
Opipari Anthony W. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Anthony W. Opipari appears in SEC filings related to Odyssey Therapeutics, Inc., as of May 12, 2026. Public information provided with these filings does not contain a detailed biographical profile. Based on the SEC context, Opipari is associated with Odyssey Therapeutics, Inc. as a director and/or executive officer, but the exact title and tenure are not disclosed in the provided materials. No additional public details about his career history, education, or achievements are available from the given SEC context.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | F — Tax withholding / forfeiture | 4 | $18.00 | $72 |
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | M — Option exercise | 541 | — | |
| 2026-05-12 | ODTX | Odyssey Therapeutics, Inc. | J — Other acquisition / disposition | 7.0K | — |
Anthony W. Opipari appears in SEC filings related to Odyssey Therapeutics, Inc., as of May 12, 2026. Public information provided with these filings does not contain a detailed biographical profile. Based on the SEC context, Opipari is associated with Odyssey Therapeutics, Inc. as a director and/or executive officer, but the exact title and tenure are not disclosed in the provid…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Opipari Anthony W. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.